Free tool
Oncology stocks
We cover 5 companies grouped under the Oncology theme. The median market value in the group is $16.01B. Across the group, the median move over the past trading day is +1.97%. Price change over the past year runs from −0.8% to +49.9% across the middle 80 percent of the group, with a median of +39.2%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
5 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| GE9.DE | GENMAB AS N | $21.11B | Large cap | −14.41% |
| 0J9P.L | Incyte Corporation | $21.10B | Large cap | +53.55% |
| IPN.PA | Ipsen S.A. | $16.01B | Large cap | +39.21% |
| 0IJO.L | Exelixis, Inc. | $14.05B | Large cap | +44.33% |
| 0M2N.L | Orion Oyj | $11.16B | Large cap | +19.68% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.